Cargando…

Influence of adjuvant radiotherapy on circulating epithelial tumor cells and circulating cancer stem cells in primary non-metastatic breast cancer

BACKGROUND: : There is an unmet need to identify biomarkers that directly reflect response to adjuvant radiotherapy (RT). Circulating epithelial tumor cells (CETCs) represent the liquid component of solid tumors and are responsible for metastatic relapse. CETC subsets with cancer stem cell character...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schott, Dorothea Sonja, Pizon, Monika, Pachmann, Ulrich, Pachmann, Katharina, Schobert, Rainer, Wittig, Andrea, Mäurer, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811056/ https://www.ncbi.nlm.nih.gov/pubmed/33453469 http://dx.doi.org/10.1016/j.tranon.2021.101009

Ejemplares similares

Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients
por: Pizon, Monika, et al.
Publicado: (2022)

Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer
por: Mäurer, Matthias, et al.
Publicado: (2022)

Sensitive detection of PD-L1 expression on circulating epithelial tumor cells (CETCs) could be a potential biomarker to select patients for treatment with PD-1/PD-L1 inhibitors in early and metastatic solid tumors
por: Schott, Dorothea Sonja, et al.
Publicado: (2017)

Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer
por: Pizon, Monika, et al.
Publicado: (2018)

Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radiotherapy of Breast Cancer Patients
por: Mäurer, Matthias, et al.
Publicado: (2021)

Insulin-Like Growth Factor Receptor I (IGF-IR) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Are Expressed on the Circulating Epithelial Tumor Cells of Breast Cancer Patients
por: Pizon, Monika, et al.
Publicado: (2013)

The number of tumorspheres cultured from peripheral blood is a predictor for presence of metastasis in patients with breast cancer
por: Pizon, Monika, et al.
Publicado: (2016)

Monitoring of circulating epithelial tumor cells using the Maintrac(®) method and its potential benefit for the treatment of patients with colorectal cancer
por: Gold, Madeleine, et al.
Publicado: (2021)

Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer
por: Pizon, M, et al.
Publicado: (2013)

Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(® )is a predictor for relapse: A preliminary report
por: Rolle, Axel, et al.
Publicado: (2005)

The Value of Monitoring the Behavior of Circulating Tumor Cells at the End of Endocrine Therapy in Breast Cancer Patients
por: Pachmann, Katharina, et al.
Publicado: (2018)

Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells
por: Camara, Oumar, et al.
Publicado: (2006)

Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring
por: Pachmann, Katharina, et al.
Publicado: (2005)

Treatment of advanced solid tumours with NSAIDs: Correlation of quantitative monitoring of circulating tumour cells and positron emission tomography-computed tomography imaging
por: Willecke-Hochmuth, Regina, et al.
Publicado: (2016)

Tumor Cell Seeding During Surgery—Possible Contribution to Metastasis Formations
por: Katharina, Pachmann
Publicado: (2011)

Efficacy control of therapy using circulating epithelial tumor cells (CETC) as “Liquid Biopsy”: trastuzumab in HER2/neu-positive breast carcinoma
por: Pachmann, Katharina, et al.
Publicado: (2011)

Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy
por: Pachmann, Katharina, et al.
Publicado: (2010)

Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer
por: Inhestern, Johanna, et al.
Publicado: (2015)

Epithelial Cell Dissemination and Readhesion: Analysis of Factors Contributing to Metastasis Formation in Breast Cancer
por: Hekimian, Katya, et al.
Publicado: (2012)

High depletion of breast cancer cells from the peripheral blood with the method of non-specific separation
por: Payer, Petra, et al.
Publicado: (2020)

Prognostic value of circulating endothelial cells in metastatic colorectal cancer
por: Rahbari, Nuh N, et al.
Publicado: (2017)

Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity
por: Koch, Claudia, et al.
Publicado: (2020)

A study of Docetaxel-induced effects in MCF-7 cells by means of Raman microspectroscopy
por: Hartmann, Katharina, et al.
Publicado: (2012)

In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy
por: Chen, Shukun, et al.
Publicado: (2019)

Circulating epithelial tumor cells in patients with metastatic breast cancer treated with bevacizumab
por: Manso, L, et al.
Publicado: (2009)

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2009)

Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
por: Brisotto, Giulia, et al.
Publicado: (2020)

The Role of Circulating Tumor Cells in Chemoresistant Metastatic Breast Cancer
por: Lisencu, Lorena Alexandra, et al.
Publicado: (2021)

Better together: circulating tumor cell clustering in metastatic cancer
por: Schuster, Emma, et al.
Publicado: (2021)

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2021)

Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer
por: Zhang, Tian, et al.
Publicado: (2021)

Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
por: Patelli, Giorgio, et al.
Publicado: (2021)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer
por: Barbazán, Jorge, et al.
Publicado: (2012)

Circulating tumor cells in non-metastatic triple-negative breast cancer
por: Karhade, Mandar, et al.
Publicado: (2014)

Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer
por: Mu, Zhaomei, et al.
Publicado: (2016)

Circulating tumor cells mirror bone metastatic phenotype in prostate cancer
por: Josefsson, Andreas, et al.
Publicado: (2018)

Androgen receptor expression on circulating tumor cells in metastatic breast cancer
por: Fujii, Takeo, et al.
Publicado: (2017)

Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds
por: Menyailo, Maxim E., et al.
Publicado: (2020)

Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer
por: Ring, Alexander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jdkd3do6v4aa753q4qun56707i